EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA

被引：216
|
作者：
MITCHELL, MS
KEMPF, RA
HAREL, W
SHAU, H
BOSWELL, WD
LIND, S
BRADLEY, EC
机构：
[1] UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90033
[4] CETUS CORP,EMERYVILLE,CA 94608
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 03期
关键词：
D O I：
10.1200/JCO.1988.6.3.409
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：409 / 424
页数：16
相关论文
共 50 条
  • [1] LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1989, 65 (01) : 128 - 144
  • [2] SUCCESSFUL THERAPY OF MELANOMA WITH A REGIMEN OF LOW-DOSE CYCLOPHOSPHAMIDE AND INTERLEUKIN-2
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    MOLECULAR AND CELLULAR NETWORKS FOR CANCER THERAPY, 1989, 857 : 61 - 74
  • [3] LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND LOW-DOSE CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER
    SPICER, DV
    KELLEY, A
    HERMAN, R
    DEAN, G
    STEVENSON, L
    MITCHELL, MS
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 34 (06) : 424 - 426
  • [4] IMMUNOTHERAPY OF MICE WITH A LARGE BURDEN OF DISSEMINATED LYMPHOMA WITH LOW-DOSE INTERLEUKIN-2
    MAAS, RA
    DULLENS, HFJ
    DEJONG, WH
    DENOTTER, W
    CANCER RESEARCH, 1989, 49 (24) : 7037 - 7040
  • [5] Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis
    Lim, Tiong Y.
    Martinez-Llordella, Marc
    Kodela, Elisavet
    Gray, Elisabeth
    Heneghan, Michael A.
    Sanchez-Fueyo, Alberto
    HEPATOLOGY, 2018, 68 (04) : 1649 - 1652
  • [6] Diabetes mellitus induced by low-dose interleukin-2
    Soni, N
    Meropol, NJ
    Porter, M
    Caligiuri, MA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (01) : 59 - 62
  • [7] Low-dose interleukin-2 for systemic lupus erythematosus?
    Wallace, Daniel J.
    LANCET RHEUMATOLOGY, 2019, 1 (01): : E7 - E8
  • [8] PHASE-II STUDY OF LOW-DOSE CYCLOPHOSPHAMIDE AND INTRAVENOUS INTERLEUKIN-2 IN METASTATIC RENAL-CANCER
    QUAN, WDY
    DEAN, GE
    LIESKOVSKY, G
    MITCHELL, MS
    KEMPF, RA
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 35 - 39
  • [9] Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide
    Lee, Young-Chul
    Park, Joon-Sung
    Lee, Chang Hwa
    Bae, Sang-Cheol
    Kim, In-Soon
    Kang, Chong Myung
    Kim, Gheun-Ho
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1520 - 1524
  • [10] Low-dose intravenous cyclophosphamide in systemic vasculitis.
    DCruz, D
    Froes, LD
    Lloyd, ME
    Khamashta, MA
    Hughes, GRV
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1151 - 1151
12345